BioArray Solutions

NEW YORK (GenomeWeb) — Immucor believes the recent US regulatory approval of its microarray-based PreciseType Human Erythrocyte Antigen test for determining blood compatibility will encourage more customers to introduce the assay in a clinical setting.

US patents awarded to Nishikawa Rubber, Virco, Bioarray Solutions, Aisin Seiki, Riken, Abacus Diagnostica, Sigma-Aldrich, Illumina, LLNL, OncoMedX, Brandeis University, and Epigenomics.

BioArray Solutions, DuPont, and Becton Dickinson awarded US patents.

CEO Gioacchino De Chirico said the postponement will have no impact on the timing of Immucor's plan to submit the system to the US Food and Drug Administration for clearance.

While the assay has been available for research use in Europe, the company believes its certification as an in vitro diagnostic will allow more users in blood banks, clinical laboratories, and blood donor centers to adopt the technology.

The company expects to obtain a CE-IVD mark for its semi-automated BeadChip array analysis system this quarter and to make a new, fully automated version of the molecular immunohematology system available for research purposes in the first half of 2011.

IP Roundup

Premium

CapitalBio, Population Genetics Technologies, Illumina, Nanogen, Gen-Probe, BioArray Solutions, Fluidigm

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.